Mauriac syndrome in adult with type 1 diabetes mellitus

Mauriac syndrome in adult with type 1 diabetes mellitus

We describe the case of Mauriac syndrome in young adult with prolonged poorly controlled type 1 diabetes mellitus.

Saved in:

Bibliographic Details
Main Authors:	Natalya Alexandrovna Molitvoslovova, Alla Yur'evna Tokmakova
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2011-09-01
Series:	Сахарный диабет
Subjects:	type 1 diabetes mellitus mauriac syndrome decompensation glargin glulisin
Online Access:	https://www.dia-endojournals.ru/jour/article/view/6236
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Mauriac syndrome: a rare complication in patients with type 1 diabetes mellitus
by: João Oliveira Torres, et al.
Published: (2025-08-01)

François Mauriac et les « charmes » du patois
by: Philippe Gardy
Published: (2007-12-01)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
by: Ivona Renata Yarek-Martynova, et al.
Published: (2011-12-01)

Effective and safe control of glycemia with insulin Apidra - the recipe for success of type 2 diabetes prophylaxis
by: Elena Valer'evna Biryukova
Published: (2011-12-01)

Ketosis-prone type 2 diabetes mellitus (review of the literature)
by: Natalya Alexandrovna Molitvoslovova,, et al.
Published: (2009-09-01)

Risk of oncological diseases in patients with diabetes mellitus
by: Gagik Radikovich Galstyan
Published: (2009-12-01)

Chronic wounds and diabetes mellitus: modern concept and prospects for conservative treatment
by: Alla Yur'evna Tokmakova, et al.
Published: (2010-12-01)

Necrobiosis lipoidica in diabetic patients: pathogenetic and clinical features
by: Daria Alexandrovna Semenova, et al.
Published: (2011-12-01)

Individualisation of basal insulin therapy of type 2 diabetes: evidence from large randomized controlled trials
by: S. V. Nedogoda, et al.
Published: (2023-01-01)

Effects of growth factors and cytokins on soft tissue regeneration in patients with diabetes mellitus
by: Ekaterina Leonidovna Zaytseva, et al.
Published: (2014-03-01)

Mauriac syndrome in an adolescent â case report: a rare complication of type 1 diabetes mellitus
by: Biana Moreira, et al.
Published: (2025-07-01)

Real World Effectiveness of fixed combination of glargine 100 U/ml and lixisenatide therapy in outpatients with Type 2 Diabetes: A Retrospective Cohort Study SOLO
by: M. B. Antsiferov, et al.
Published: (2022-05-01)

Modern technology for the treatment of type 1 diabetes mellitus with end-stage renal failure
by: Yulia Alexandrovna Krupinova, et al.
Published: (2015-06-01)

Metabolic and cardiovascular effects of early insulin glargin prescription: based on data from ORIGIN study
by: Elena Valer'evna Biryukova, et al.
Published: (2012-09-01)

Genetic framework of type 2 diabetes mellitus
by: Irina Arkad'evna Bondar', et al.
Published: (2013-12-01)

Real-world effectiveness and safety of fixed-ratio combination insulin glargine 100 u/ml plus lixisenatide in adults with type 2 diabetes (T2DM): subanalysis of the international, multicentre, prospective observational study SUCCESS in the Russian population
by: O. K. Vikulova, et al.
Published: (2024-11-01)

Anemia in patients with type 1 diabetes mellitus
by: Tatiana Yur'evna Kufelkina, et al.
Published: (2010-12-01)

Osteoporosis and diabetes mellitus: a modern viewpoint
by: Natalya Alexandrovna Molitvoslovova, et al.
Published: (2013-03-01)

Epidemiology and ecology of type 1 diabetes mellitus in children and adolescents of Krasnodar Region
by: Irina Yur'evna Chernyak, et al.
Published: (2013-09-01)

On the safety of insulin Glargine
by: Ivan Ivanovich Dedov, et al.
Published: (2009-09-01)

Use of vacuum therapy in diabetic foot patients. Third Congress of the World Union of Wound Healing Societies. Toronto 2008
by: Lyudmila Petrovna Doronina, et al.
Published: (2009-03-01)

The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus
by: Nina Viktorovna Bolotova, et al.
Published: (2010-12-01)

Prescription characteristics of the insulin glargine plus lixisenatide fixed-ratio combination in real-world clinical practice according to the Registry of Diabetes Mellitus in the Moscow Region
by: Inna V. Misnikova, et al.
Published: (2024-12-01)

Assessment of carotid intima-media thickness in patients with type 2 diabetes mellitus and arterial hypertension
by: Irina Arkad'evna Bondar', et al.
Published: (2014-03-01)

Insulin glargine does not increase the risk of malignancy.Synopsis of the article ?Combined randomised controlled trial experience of malignancies in studies using insulin glargine?byHome P.D. & Lagarenne P. (Diabetologia 2009, vol. 52 (12): 2499-2506)
by: Marina Vladimirovna Shestakova, et al.
Published: (2010-03-01)

Dynamics of incidence and prevalence of type 1 diabetes mellitus in children in the Russian Federation (2001-2007)
by: Tatiana Yur'evna Shiryaeva, et al.
Published: (2009-09-01)

Neurohumoral mechanisms of keratinocytes regulation in diabetes mellitus
by: Ekaterina Viktorovna Artemova, et al.
Published: (2016-11-01)

Dynamics of main epidemiological characteristics of type 1 diabetes mellitus in children of the Russian Federation
by: Tatiana Yur'evna Shiryaeva, et al.
Published: (2010-12-01)

Integrated surgical management of neuroischemic diabetic foot syndrome, abdominal aortic aneurysm and renal artery lesionsin patients with diabetes mellitus type 2
by: Sergey Anatol'evich Terekhin, et al.
Published: (2011-12-01)

American Diabetes Association proposes to use HbA1c level for diagnosis of diabetes mellitus
by: Olga Yur'evna Sukhareva
Published: (2009-12-01)

Type 1 diabetes mellitus in children and adolescents of Russian Federation: key epidemiology trends
by: Tatiana Yur'evna Shiryaeva, et al.
Published: (2013-09-01)

Adverse drug events associated with insulin glargine: a real-world pharmacovigilance study based on the FAERS database
by: Tongtong Wang, et al.
Published: (2025-04-01)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
by: Alsu Gafurovna Zalevskaya, et al.
Published: (2010-06-01)

Vacuum therapy for chronic wounds
by: Ekaterina Leonidovna Zaytseva, et al.
Published: (2012-09-01)

Up-to-date principles of diagnostics and treatment of chronic wound in diabetic foot patients
by: Alla Yur'evna Tokmakova
Published: (2009-03-01)

Effects of regular, glulisine, and aspart insulin on vascular endothelial growth factor and angiotensinogen expression in hyperglycemic retinal pigment epithelial (RPE) and human retinal endothelial cells (HRECs)
by: Fatemeh Sanie-Jahromi, et al.
Published: (2025-05-01)

Algorithms of Specialized Medical Care for Diabetes Mellitus Patients
by: Ivan Ivanovich Dedov, et al.
Published: (2011-09-01)

Rs7903146 variant of TCF7L2 gene and rs18012824 variant of PPARG2 gene (Pro12Ala) are associated with type 2 diabetes mellitus in Novosibirsk population
by: Irina Arkad'evna Bondar', et al.
Published: (2013-12-01)

CORRECTION OF CARBOHYDRATE METABOLISM BY USING THE APPARATUS OF INSULIN THERAPY IN PATIENTS WITH DIABETES MELLITUS AFTER RENAL TRANSPLANTATION
by: V. K. Novikov, et al.
Published: (2012-05-01)

Effect of negative pressure therapy on repair of soft tissues of the lower extremities in patients with neuropathic and neuroischaemic forms of diabetic foot syndrome
by: Ekaterina Leonidovna Zaytseva, et al.
Published: (2014-10-01)